Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1989 Apr;42(4):371–377. doi: 10.1136/jcp.42.4.371

Mucosal argyrophil endocrine cells in pernicious anaemia and upper gastrointestinal carcinoid tumours.

S M Sjöblom 1, P Sipponen 1, S L Karonen 1, H J Järvinen 1
PMCID: PMC1141907  PMID: 2715350

Abstract

The number and density of argyrophil endocrine cells were morphometrically calculated in gastric fundal mucosal biopsy specimens taken from 64 patients with pernicious anaemia (five with gastric carcinoids, 15 with nodular argyrophil cell hyperplasia, 44 with diffuse argyrophil cell hyperplasia) and from 14 healthy controls. Similar calculations were also made on the ileal mucosa away from the tumour of 10 patients with ileal carcinoids and 10 controls. In the stomach, the argyrophil cell counts were twice as high in the patients with pernicious anaemia than in controls and the densities in the whole mucosa or in the epithelial structures were similarly three to five times higher. The cell counts in the patients showed positive correlation with the serum gastrin concentration. The patients with nodular argyrophil cell hyperplasia and gastric carcinoids formed a uniform group with the highest cell counts and serum gastrin concentrations; the difference between the groups was in the longer duration of pernicious anaemia in the patients with carcinoid tumours. On the other hand, no endocrine cell hyperplasia was seen in those with ileal carcinoids. It is concluded that fundal mucosal endocrine cells show an increase in patients with pernicious anaemia that is related to the gastrin concentration. This phenomenon may favour the development of hyperplastic endocrine cell nodules and, eventually, carcinoid tumours.

Full text

PDF
371

Images in this article

372Fig 1
on p.372
373Fig 2
on p.373

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borch K., Renvall H., Kullman E., Wilander E. Gastric carcinoid associated with the syndrome of hypergastrinemic atrophic gastritis. A prospective analysis of 11 cases. Am J Surg Pathol. 1987 Jun;11(6):435–444. doi: 10.1097/00000478-198706000-00004. [DOI] [PubMed] [Google Scholar]
  2. Borch K., Renvall H., Liedberg G., Andersen B. N. Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa. Scand J Gastroenterol. 1986 Apr;21(3):357–363. doi: 10.3109/00365528609003087. [DOI] [PubMed] [Google Scholar]
  3. Borch K., Renvall H., Liedberg G. Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology. 1985 Mar;88(3):638–648. doi: 10.1016/0016-5085(85)90131-3. [DOI] [PubMed] [Google Scholar]
  4. Bordi C., Cocconi G., Togni R., Vezzadini P., Missale G. Gastric endocrine cell proliferation. Association with Zollinger-Ellison syndrome. Arch Pathol. 1974 Oct;98(4):274–278. [PubMed] [Google Scholar]
  5. Carney J. A., Go V. L., Fairbanks V. F., Moore S. B., Alport E. C., Nora F. E. The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy. Ann Intern Med. 1983 Dec;99(6):761–766. doi: 10.7326/0003-4819-99-6-761. [DOI] [PubMed] [Google Scholar]
  6. Godwin J. D., 2nd Carcinoid tumors. An analysis of 2,837 cases. Cancer. 1975 Aug;36(2):560–569. doi: 10.1002/1097-0142(197508)36:2<560::aid-cncr2820360235>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  7. Grimelius L., Wilander E. Silver stains in the study of endocrine cells of the gut and pancreas. Invest Cell Pathol. 1980 Jan-Mar;3(1):3–12. [PubMed] [Google Scholar]
  8. Harleman J. H., Betton G. R., Dormer C., McCrossan M. Gastric neuroendocrine cell hyperplasia after treatment with the long-acting, potent H2-receptor antagonist SK&F 93479. Scand J Gastroenterol. 1987 Jun;22(5):595–600. doi: 10.3109/00365528708991904. [DOI] [PubMed] [Google Scholar]
  9. Harvey R. F., Bradshaw M. J., Davidson C. M., Wilkinson S. P., Davies P. S. Multifocal gastric carcinoid tumours, achlorhydria, and hypergastrinaemia. Lancet. 1985 Apr 27;1(8435):951–954. doi: 10.1016/s0140-6736(85)91727-1. [DOI] [PubMed] [Google Scholar]
  10. Havu N. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion. 1986;35 (Suppl 1):42–55. doi: 10.1159/000199381. [DOI] [PubMed] [Google Scholar]
  11. Hedinger C., Hardmeier T., Funk H. U. Das argentaffine System des Verdauungstraktes bei Carcinoidsyndrom. Virchows Arch Pathol Anat Physiol Klin Med. 1966 Feb 22;340(4):304–311. [PubMed] [Google Scholar]
  12. Håkanson R., Böttcher G., Sundler F., Vallgren S. Activation and hyperplasia of gastrin and enterochromaffin-like cells in the stomach. Digestion. 1986;35 (Suppl 1):23–41. doi: 10.1159/000199380. [DOI] [PubMed] [Google Scholar]
  13. Johansson H., Wilander E. A clinical study of 30 gastric carcinoids. Ups J Med Sci. 1982;87(2):135–142. doi: 10.3109/03009738209178418. [DOI] [PubMed] [Google Scholar]
  14. MOERTEL C. G., SAUER W. G., DOCKERTY M. B., BAGGENSTOSS A. H. Life history of the carcinoid tumor of the small intestine. Cancer. 1961 Sep-Oct;14:901–912. doi: 10.1002/1097-0142(196109/10)14:5<901::aid-cncr2820140502>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  15. Mendelsohn G., de la Monte S., Dunn J. L., Yardley J. H. Gastric carcinoid tumors, endocrine cell hyperplasia, and associated intestinal metaplasia. Histologic, histochemical, and immunohistochemical findings. Cancer. 1987 Sep 1;60(5):1022–1031. doi: 10.1002/1097-0142(19870901)60:5<1022::aid-cncr2820600517>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  16. Mignon M., Lehy T., Bonnefond A., Ruszniewski P., Labeille D., Bonfils S. Development of gastric argyrophil carcinoid tumors in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long-term antisecretory treatment. Cancer. 1987 Jun 1;59(11):1959–1962. doi: 10.1002/1097-0142(19870601)59:11<1959::aid-cncr2820591120>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  17. Mizuma K., Shibuya H., Totsuka M., Hayasaka H. Carcinoid of the stomach: a case report and review of 100 cases reported in Japan. Ann Chir Gynaecol. 1983;72(1):23–27. [PubMed] [Google Scholar]
  18. Mårtensson H., Nobin A., Sundler F. Carcinoid tumors in the gastrointestinal tract--an analysis of 156 cases. Acta Chir Scand. 1983;149(6):607–616. [PubMed] [Google Scholar]
  19. Müller J., Kirchner T., Müller-Hermelink H. K. Gastric endocrine cell hyperplasia and carcinoid tumors in atrophic gastritis type A. Am J Surg Pathol. 1987 Dec;11(12):909–917. doi: 10.1097/00000478-198712000-00001. [DOI] [PubMed] [Google Scholar]
  20. Poynter D., Pick C. R., Harcourt R. A., Selway S. A., Ainge G., Harman I. W., Spurling N. W., Fluck P. A., Cook J. L. Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat. Gut. 1985 Dec;26(12):1284–1295. doi: 10.1136/gut.26.12.1284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rbin W. Proliferation of endocrine-like enterochromaffin) cells in atrophic gastri mucosa. Gastroenterology. 1969 Dec;57(6):641–648. [PubMed] [Google Scholar]
  22. Rehfeld J. F., Stadil F., Vikelsoe J. Immunoreactive gastrin components in human serum. Gut. 1974 Feb;15(2):102–111. doi: 10.1136/gut.15.2.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sherman S. P., Li C. Y., Carney J. A. Microproliferation of enterochromaffin cells and the origin of carcinoid tumors of the ileum: a light microscopic and immunocytochemical study. Arch Pathol Lab Med. 1979 Nov;103(12):639–641. [PubMed] [Google Scholar]
  24. Solcia E., Capella C., Buffa R., Usellini L., Fiocca R., Frigerio B., Tenti P., Sessa F. The diffuse endocrine-paracrine system of the gut in health and disease: ultrastructural features. Scand J Gastroenterol Suppl. 1981;70:25–36. [PubMed] [Google Scholar]
  25. Solcia E., Capella C., Sessa F., Rindi G., Cornaggia M., Riva C., Villani L. Gastric carcinoids and related endocrine growths. Digestion. 1986;35 (Suppl 1):3–22. doi: 10.1159/000199378. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES